One CRO. Every Critical Capability.
We provide specialized Phase I clinical trial services focused on safety and scientific
precision.
Our expertise includes FIH, SAD, MAD, and PK/PD studies.
Robust operational oversight ensures reliable, high-quality clinical data.
We support programs with confidence from early development to the next stage.
We conduct reliable bioavailability and bioequivalence studies for generic drugs.
Our integrated clinical and GLP-compliant bioanalytical operations ensure quality data.
PK analysis and biostatistics support accurate and regulatory-ready results.
We focus on data integrity and readiness for regulatory submission.
We support medical device trial focused on safety and
performance.
Our clinical investigations and usability studies generate robust
evidence. Studies are aligned with ISO 14155 and EU MDR requirements. We support partners from
study planning through regulatory submission.
Experience that extends beyond the numbers.
The discipline behind every study we support.
Quality and compliance shape every stage of our clinical research operations. From study conduct and bioanalytical testing to data management and reporting, our systems are designed to support consistent execution, reliable data, and regulatory confidence across globally regulated development programs.
Proven Across Complex Disease Areas.
Our Phase I and BA/BE experience spans diverse therapeutic areas, supporting studies requiring specialized safety oversight, PK/PD evaluation, and protocol-specific clinical execution.
Our clinical teams have supported medical device investigations across diverse therapeutic domains, generating the clinical evidence required for regulatory evaluation, performance assessment, and market access.
Where Critical Studies Get Done Right.
Complex studies demand more than infrastructure. They demand control, consistency, and confidence at every stage of execution. Ordoclin brings together clinical research, bioanalytical sciences, biometrics, and regulatory operations within a connected framework built to support globally regulated development programs.
Whether supporting early-phase research, bioequivalence programs, or medical device investigations, our focus remains the same: disciplined execution, reliable data, and research environments designed to meet the expectations of partners, regulators, and global development teams.
